News & Articles

New findings pave way to potentially improved assessment of measurable residual disease in AML patients

The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes

Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min

Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time

Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month

Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods

Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more

For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics

In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years

Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery

KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics

First rapid antigen test with performance data on children

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems